E-LIB Suche - Ergebnisse für: Pullman, John

1

The Impact of Sensory Modulation Interventions on Practice ..:

Molloy, Luke ; Chidarikire, Sherphard ; Pullman, John...
Issues in Mental Health Nursing. 45 (2024) 6 - p. 580-588 , 2024

Link: https://doi.org/10.1080/..

2

P29 Treatment outcomes with rezafungin and caspofungin in p..:

Cornely, Oliver A ; Thompson, George R ; Soriano, Alex...
JAC-Antimicrobial Resistance. 6 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

3

Integrated Safety and Efficacy Analyses of Phase 3 Trials o..:

Kraft, Colleen S. ; Sims, Matthew ; Silverman, Michael...
Infectious Diseases and Therapy. , 2024

Link: https://doi.org/10.1007/..

4

Efficacy and safety of rezafungin and caspofungin in candid..:

Thompson III, George R ; Soriano, Alex ; Honore, Patrick M...
The Lancet Infectious Diseases. 24 (2024) 3 - p. 319-328 , 2024

Link: https://doi.org/10.1016/..

5

Rezafungin versus caspofungin for treatment of candidaemia ..:

Thompson III, George R ; Soriano, Alex ; Cornely, Oliver A...
The Lancet. 401 (2023) 10370 - p. 49-59 , 2023

Link: https://doi.org/10.1016/..

6

Prevalence of Comorbid Factors in Patients With Recurrent C..:

Berenson, Charles S ; Lashner, Bret ; Korman, Louis Y...
Clinical Infectious Diseases. 77 (2023) 11 - p. 1504-1510 , 2023

Link: https://doi.org/10.1093/..

7

Impact of strengths model training and supervision on the t..:

Pullman, John ; Santangelo, Peter ; Molloy, Luke.
International Journal of Mental Health Nursing. 32 (2022) 1 - p. 236-244 , 2022

Link: https://doi.org/10.1111/..

8

634. Investigational Microbiome Therapeutic SER-109 Reduces..:

Cohen, Stuart H ; Louie, Thomas J ; Sims, Matthew...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S420-S420 , 2021

Link: https://doi.org/10.1093/..

9

1503. Engraftment of Investigational Microbiome Drug, SER-2..:

Ford, Christopher ; Litcofsky, Kevin ; McGovern, Barbara...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S547-S548 , 2019

Link: https://doi.org/10.1093/..

10

2234. Outcomes by Age and Gender from a Global Phase 3 Stud..:

Madej, Andrzej ; Pullman, John ; Popescu, Monica...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S763-S763 , 2019

Link: https://doi.org/10.1093/..

11

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) fol..:

Spec, Andrej ; Pullman, John ; Thompson III, George R...
Journal of Antimicrobial Chemotherapy. 74 (2019) 10 - p. 3056-3062 , 2019

Link: https://doi.org/10.1093/..

12

Bone and Joint Tissue Penetration of theStaphylococcus-Sele..:

Menetrey, Annick ; Janin, Annick ; Pullman, John...
Antimicrobial Agents and Chemotherapy. 63 (2019) 3 - p. , 2019

Link: https://doi.org/10.1128/..

13

Changes in Mental Health Providers' Recovery Attitudes and ..:

Deane, Frank P. ; Goff, Roxanne O. ; Pullman, John..
International Journal of Mental Health and Addiction. 17 (2018) 6 - p. 1417-1431 , 2018

Link: https://doi.org/10.1007/..

14

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacte..:

Pullman, John ; O'Riordan, William ; Lawrence, Laura...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S708-S708 , 2018

Link: https://doi.org/10.1093/..

15

Efficacy and safety of ridinilazole compared with vancomyci..:

Vickers, Richard J ; Tillotson, Glenn S ; Nathan, Richard...
The Lancet Infectious Diseases. 17 (2017) 7 - p. 735-744 , 2017

Link: https://doi.org/10.1016/..